<DOC>
	<DOC>NCT01204255</DOC>
	<brief_summary>RATIONALE: Lorazepam, diphenhydramine hydrochloride, and haloperidol gel, when absorbed into the skin, may be an effective treatment for nausea and vomiting.PURPOSE: This clinical trial studies lorazepam, diphenhydramine hydrochloride, and haloperidol gel in healthy volunteers.</brief_summary>
	<brief_title>Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers</brief_title>
	<detailed_description>OBJECTIVES:I. To study the absorption of the three components in the topical ABH gel in 10 healthy volunteers, and determine if there are any adverse effects. OUTLINE: Patients apply lorazepam, diphenhydramine hydrochloride, and haloperidol gel topically over 2 minutes. After completion of study treatment, patients are followed up for 5 hours.</detailed_description>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>Completed a medical screening questionnaire English speaking No allergies to the drugs Able to complete the forms If a woman of childbearing age, agree to use contraception History of substance abuse, psychiatric disorder, acquired brain injury, the possibility of pregnancy (not using birth control, and of child bearing age) Use of any medication that would contraindicate benzodiazepine administration Pregnant or nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>healthy, no evidence of disease</keyword>
</DOC>